Objective: Sepsis impairs the activation of the interleukin (IL)-6 dependent transcription factor signal transducer and activator of transcription (STAT)-3. However, the molecular basis for depressed functionality has not been characterized. In this study, we test the hypothesis that altered signal transduction results from a change in the activation state of one or more of the components of the intracellular IL-6-linked pathway.
S epsis is a leading cause of morbidity and mortality in noncoronary intensive care units. The syndrome is associated with approximately 215,000 deaths each year (1) . Mortality is typically due to the multiple-organ dysfunction syndrome. Multiple-organ dysfunction syndrome is characterized by dysfunction in nearly all organ systems including the liver (2). This process is mediated, in part, by cytokines such as interleukin-6 (IL-6). However, the role played by IL-6 in sepsis/multiple-organ dysfunction syndrome is unclear. IL-6 has been reported to be an excellent marker for mortality in animals and humans, but there is debate regarding the importance of this mediator's contribution to the pathologic process (3) . Although some believe that IL-6 is most valuable as a biomarker, studies in our laboratory have shown a sepsisinduced decrease in IL-6 activity that parallels the progression of organ dysfunction, especially in the liver. Specifically, previous investigations in a rat model of mild sepsis (cecal ligation and single puncture [CLP]) demonstrated a sustained increase in signal transducer and activator of transcription (STAT)-3 DNA binding activity over 72 hours (4) . This was accompanied by an increase in the transcription of IL-6-dependent genes. However, we observed an abrupt loss of STAT-3 DNA binding activity 16 hours after the induction of fulminant sepsis via cecal ligation and double puncture (2CLP). This latter finding paralleled both gene expression and mortality (4) . Our observations suggested that STAT-3 activation via IL-6 is necessary for survival and that fulminant sepsis is characterized by a loss of cell signaling, a conclusion supported by additional studies in IL-6 Ϫ/Ϫ mice (5) . Because IL-6 levels in this model are known to be elevated (3, 6) , it is logical to surmise that there is an abnormality in the IL-6/STAT-3 signal transduction pathway.
Activation of the IL-6 pathway involves the transmembrane cell surface receptor glycoprotein (gp)130. With IL-6 binding, gp130 dimerizes and induces the phosphorylation of janus kinase (JAK)-1. Once phosphorylated, JAK-1 itself acts as a kinase and phosphorylates a number of tyrosine residues on the intracytoplasmic tail of gp130. Importantly, gp130 and JAK-1 are tightly linked, and this association is believed to be important to both gp130 and JAK-1 kinase activity. The gp130 tyrosine residues serve as docking sites for STAT-3 with transfer of a phosphate group to SH-2 sites on the transcription factor. Phosphorylated STAT-3 (p-STAT-3) dimerizes, translocates to the nucleus, and induces organ-specific gene expression (7) . Therefore, we hypothesize that sepsis alters either the abundance or phosphorylation of gp130 or JAK-1, or the association of gp130 with JAK-1. This, in turn, would result in failed STAT-3 nuclear translocation and DNA binding.
MATERIALS AND METHODS
Animals. Animal procedures and handling adhered to National Institutes of Health standards and were approved by the Institutional Animal Care and Use Committee. Male C57/ Bl6 mice, 6 -8 weeks old (Charles River, Boston, MA) were used in all experiments.
Induction of Sepsis. Under isoflurane anesthesia, mild, nonfulminant sepsis was induced via CLP with a 23-gauge needle, as previously described (8) . Fulminant sepsis was performed in a similar manner, but the cecum was punctured twice (2CLP). Control animals were either anesthetized only (T 0 ) or subjected to sham operation (SO), where the cecum was manipulated but not ligated or punctured. Following surgery, animals were fluid resuscitated with 40 mL/kg of subcutaneously administered normal saline. At 3, 6, 16, 24, 48 , and 72 hours following surgery, animals were reanesthetized with 150 mg/kg pentobarbital sodium. Animals were exsanguinated via the vena cava, with blood being reserved for serum assays.
There are two important aspects to the study design. First, our long-used study design required that animals be sacrificed at a specific time point. Therefore, based on previous data, we performed enough procedures to assure that three animals survived to each time point. In effect, this constitutes something of an "intention-to-treat" design. To expand, although there were no deaths in the SO or CLP groups, there was significant mortality in the 2CLP group. Therefore, we performed 2CLP in six animals designated to survive for 24 hours, 12 animals designated to survive for 48 hours, and 30 animals designated to survive for 72 hours. Because of this design, our data have an inherent survival bias. Second, all animals to be included in a cohort (defined as one T 0 , one T 3 , one T 6 , one T 16 , one T 24 , one T 48 , and one T 72 ) were designated to be part of that group in advance, and the intervention (SO, CLP, 2CLP) was also designated in advance. SO, CLP, or 2CLP was performed on a complete cohort on the same day. This assured that the data obtained from one T 0 animal were used to normalize all other animals in the same cohort, permitting us to design our blots to include a full-time course of data.
Isolation of Liver Protein Fractions. Liver tissue was harvested immediately following exsanguinations, and both nuclear and cytosolic protein fractions were isolated. All isolation procedures were performed on ice or at 4°C and in the presence of the protease inhibitors, antipain, aprotinin, bestatin, and leupeptin, and the phosphatase inhibitors, phenylmethylsulfonyl fluoride, NaF, Na 2 MoO 4 , and Na 3 VO 4 . Nuclear and cytosolic protein fractions were harvested and homogenized as previously described (9, 10) . Briefly, samples were centrifuged at 83,000g (26,000 rpm) for 50 minutes to separate the cytosolic fraction (supernatant) from intact nuclei (pellet). Nuclear proteins were then isolated from the pellet.
Immunoprecipitation from the Cytosolic Protein Fraction. Cytosolic protein, 500 g, was diluted to a final concentration of 1 g/L with phosphate-buffered saline, pH 7.4. For gp130 immunoprecipitation, samples were precleared for 30 minutes at 4°C with 50 L of a 50% Protein G sepharose bead slurry. The beads were subsequently removed by centrifugation. gp130 rabbit polyclonal IgG (1.6 g; Santa Cruz Biotechnology, Santa Cruz, CA) was incubated overnight at 4°C using circular rotation. Following this, 100 L of 50% Protein G sepharose beads in phosphate-buffered saline was added, and each sample was placed in a circular rotator and incubated overnight. After centrifugation, the supernatant was discarded and the bead pellet was saved. The beads were washed three times with a modified RIPA buffer (50 mM Tris-HCl and 150 mM NaCl, pH to 7.4, 10% NP-40, 10% Nadeoxylate, 0.5 M EDTA ϩ protease and phosphatase inhibitors). For JAK-1 immunoprecipitation, the same procedure was followed, but a 50% slurry of Protein A sepharose beads and 1.6 g of JAK-1 IgG rabbit polyclonal (Santa Cruz) were used. After the final wash, 75 L of 2 ϫ Laemmli buffer was added to the beads and the mixture boiled for 5 minutes. The resultant supernatant was subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis.
Immunoblotting. All procedures were performed at room temperature. Sodium dodecyl sulfate polyacrylamide gel electrophoresis gels (8%) containing 20 g of sample/well were transferred to polyvinylidene fluoride (BioRad, Hercules, CA) using electroblotting. After transfer, membranes were rinsed and blocked for 2 hours at room temperature in a 5% (w/v) blocking solution (nonfat dry milk in Trisbuffered saline pH 7.6 with 0.001% Tween-20). After blocking, membranes were probed for 2 hours with antibodies directed at gp130, phosphorylated (p)-gp130, JAK-1, phosphorylated (p)-JAK-1, STAT-3, or tyrosine-p-STAT-3 (Santa Cruz) using a 1:1000 dilution. Next, membranes were incubated for 1 hour with species-specific secondary antibodies (Santa Cruz) added in a 1:2000 dilution. Protein bands were visualized using enhanced chemiluminescence (Amersham, Piscataway, NJ). Abundance was quantified using densitometry.
Electrophoretic Mobility Shift Assay for STAT-3. Nuclear protein extracts (5 g) were incubated at room temperature in an equal volume of reaction buffer (10 mM HEPES/ potassium hydroxide pH 7.8, 50 mM KCl, 1 mM ethylenediaminetetraacetic acid, 5 mM MgCl 2 , 5 mM dithiothreitol, and 10% glycerol) and 1 L of poly(dI-dC) for 15 minutes. For supershift assays, 1 L of antimouse monoclonal p-STAT-3 antibody (Santa Cruz) was added to the incubation mixture for 1 hour. One microliter of a radiolabeled (100,000 cpm) oligonucleotide that consisted of the sequence for the STAT-3 DNA binding site was added to each reaction mixture and incubated at room temperature for 15 minutes. For cold compe-tition, 3 L of unlabeled oligonucleotide was added at the time of incubation. Samples were loaded on a 5% nondenaturing TBE-polyacrylamide gel for electrophoresis (300 V, 2 hours, 4°C). The gels were dried and autoradiography was performed (exposure time 6 hours). Abundance was quantified using densitometry.
Determination of IL-6 Levels in Vena Caval Blood. Determinations of IL-6 serum concentrations were performed using a BD Cytometric Bead Array Mouse Inflammation Kit (BD Biosciences, San Jose, CA) via flow cytometry. IL-6 concentrations were determined from a standard curve. The lower limit for IL-6 detection was 20 pg/mL.
Statistics. Statistical significance (p Ͻ 0.05) was determined using analysis of variance for repeated measures with the Bonferroni test for post hoc significance.
RESULTS
Outcome Following 2CLP is Different From That Following Sham Operation or CLP. As noted, our study involved an intention-to-treat design. Therefore, we performed SO and CLP on three animals at each of seven time points. In this study, there was no mortality following either SO or CLP. However, because previous investigations indicated that 2CLP was often fatal after 16 hours, we performed 2CLP on a larger number of animals. These data reveal no mortality at 3, 6, or 16 hours following 2CLP. However, mortality following 2CLP was 50% (3/6) at 24 hours, 66.7% (8/12) at 48 hours, and 86.67% (26/30) at 72 hours. These data allow us to correlate IL-6 signaling data with outcome.
CLP and 2CLP Induce Different Changes in STAT-3 DNA Binding Activity. Previous investigations in rats had demonstrated a failure to activate STAT-3, the primary IL-6-dependent transcription factor, following 2CLP (3). Therefore, we examined the effects of CLP and 2CLP on the DNA binding activity of STAT-3 in our mouse model ( Fig. 1 ). No STAT-3 DNA binding activity was detected at baseline or following SO. As noted previously (3), STAT-3 DNA binding peaked around 3 hours after CLP and decreased afterward but never reached baseline levels. In 2CLP, we found a less pronounced rise in STAT-3 DNA binding than that observed following CLP at 3, 6, and 16 hours. However, STAT-3 DNA binding activity became virtually undetectable between 16 and 24 hours after 2CLP. This indicates an alteration in some phase of the activation of the IL-6 signal transduction pathway.
CLP and 2CLP Induce Different Changes in the Nuclear Abundance of p-STAT-3. Binding of STAT-3 to DNA and initiation of IL-6-dependent transcription require that STAT-3 be phosphorylated and form homodimers that translocate into the nucleus. One possible contribution to failed IL-6 signal transduction is impaired nuclear translocation of p-STAT-3. This would result in low intranuclear p-STAT-3 abundance. We examined this following SO, CLP, and 2CLP. Results are detailed in Figure 2. Intranuclear p-STAT-3 abundance was unchanged following SO. CLP was associated with increased abundance of STAT-3 in the nuclear fraction at 3, 6, 16, 24, and 48 hours, peaking at the 6-hour time point. Levels at 72 hours were statistically indistinguishable from those observed at T 0 . Abundance increased at 3 and 6 hours following 2CLP but returned to basal levels by 16 hours. This is consistent with, and might explain, the observed loss of DNA binding activity.
2CLP is Not Associated With p-STAT-3 Retention in the Cytoplasm. One possible explanation for low abundance of p-STAT-3 in the nucleus following 2CLP is retention of p-STAT-3 in the cytoplasm. This could reflect a failure of p-STAT-3 to migrate or an active expulsion of this protein from the nucleus back into the cytoplasm. Therefore, we examined cytoplasmic p-STAT-3 abundance following SO, CLP, and 2CLP. No p-STAT-3 was detectable under any condition (data not shown). This reflects the limited activation observed after SO and the high migration into the nucleus that likely accompanied CLP. However, the low levels observed both in the cytoplasm and the nucleus following 2CLP can be explained only by an absence of p-STAT-3. This, in turn, must reflect either failed phosphorylation or active degradation.
2CLP is Associated With Increased STAT-3 Abundance in the Cytoplasm. One possible explanation for low p-STAT-3 in both the nucleus and the cytoplasm is depletion of STAT-3. This could result either from failed synthesis or active degradation. To investigate this, we isolated cytoplasmic fractions and measured STAT-3 abundance following SO, CLP, and 2CLP. These data are detailed in Figure 3 . STAT-3 abundance was decreased significantly at 3, 6, and 16 hours following SO. Cytoplasmic abundance of STAT-3 was similarly decreased following CLP. These latter findings paralleled increases in the intranuclear compartment. Abundance began to return to baseline, 24 hours after CLP but never fully achieved basal levels. Following 2CLP, we observed an early decrease in cytoplasmic STAT-3 abundance similar to that observed in SO and CLP. However, by 24 hours after 2CLP, abundance had returned to baseline and became elevated significantly at 48 and 72 hours. As with SO and CLP, these findings are reciprocal to intranuclear levels and STAT-3 DNA binding activity. Of importance, observed immunoblot bands had a molecular weight of ϳ92 kDa, indicating that they reflect STAT-3 monomers. Therefore, failed intranuclear translocation of STAT-3 did not reflect absent STAT-3 but likely was because of failed STAT-3 nuclear transmigration. Further, the intracytoplasmic retention of STAT-3 monomer coupled with the absence of p-STAT-3 noted above indicates a failure of dimerization that is consistent with failed phosphorylation.
Sepsis Does Not Alter the Abundance of the Key IL-6-Linked Signal Transduction Proteins gp130 or JAK-1. The signal transduction complex that links extracellular IL-6 with the cytoplasmic protein STAT-3 consists of two proteins: the transmembrane protein gp130 and the associated protein JAK-1. These are covalently linked. Decreased abundance of either could explain failed STAT-3 phosphorylation and, thus, the low levels of IL-6 signal transduction following 2CLP. Therefore, we used immunoblotting to examine the abundance of gp130 and JAK-1 at different time points following SO, CLP, and 2CLP. These data demonstrated that the abundance of both gp130 and JAK-1 was unchanged by SO, CLP, or 2CLP (data not shown).
Sepsis Does Not Alter Phosphorylation of JAK-1. gp130 contains both transmembrane and intracytoplasmic components. The intracytoplasmic portion closest to the cell membrane is closely associated with JAK-1. On association with IL-6, gp130 dimerizes and undergoes a conformational change that catalyzes the phosphorylation of JAK-1. This, in turn, enables JAK-1 kinase activity, an action that results in phosphorylation and activation of gp130. Therefore, we used immunoprecipitation and immunoblotting to examine phosphorylation of JAK-1 following SO, CLP, and 2CLP. Although phospho-JAK-1 was de-tected in all three interventions and at all time points, no change in the intracytoplasmic abundance of p-JAK-1 was observed following SO, CLP, or 2CLP (Fig. 4B) . Therefore, failed STAT-3 phosphorylation cannot be explained by impairment of JAK-1 phosphorylation.
Sepsis Alters Phosphorylation of gp130. IL-6-mediated dimerization and activation of the gp130 -JAK-1 complex result in JAK-1-mediated phosphorylation of gp130 at several specific tyrosine residues. These provide the phosphorylation site as well as the phosphate group that is transferred to STAT-3. Although the phosphorylation of JAK-1 is not altered, kinase activity might be impaired following 2CLP. This would prevent tyrosine phosphorylation of gp130 and, thus, of STAT-3. Therefore, we immunoprecipitated gp130 and determined the abundance of the phosphorylated form of the protein following SO, CLP, and 2CLP (Fig. 4A ). SO induced a minimal change in the phosphorylation state of gp130. CLP dramatically increased p-gp130 abundance. This was apparent almost immediately following the induction of sepsis, peaked at 6 hours, and retuned toward, but never reached, baseline. In contrast, we observed a peak increase in p-gp130 6 hours after 2CLP. However, levels of p-gp130 were virtually undetectable at all later times post-2CLP. This is consistent with the time course of decreased STAT-3 activation and IL-6-dependent gene expression. Thus, failed gp130 phosphorylation represents a logical explanation of 2CLPassociated impairment of IL-6 activity.
Sepsis Does Not Cause Disassociation of gp130 and JAK-1. gp130 and JAK-1 must be associated to induce proper phosphorylation. Thus, disassociation of the gp130 -JAK-1 complex would explain the improper phosphorylation of gp130. To test this, we used an antibody directed at gp130 to immunoprecipitate and performed immunoblotting with an antibody to JAK-1. For completeness, we also performed the reverse-immunoprecipitating with an antibody to JAK-1 and immunoblotting with an antibody to gp130. These investigations showed that the association between gp130 and JAK-1 was unaffected by either CLP or 2CLP ( Fig. 5 ). Therefore, dissociation of gp130 and JAK-1 and a resultant failure of the kinase activity of either cannot explain the loss of gp130 phosphorylation following 2CLP.
CLP/2CLP Increases IL-6 Serum Levels. Finally, the sepsis-induced alteration in IL-6 signal transduction might result from a decrease in the extracellular concentration of IL-6. To investigate this possibility, we examined serum IL-6 levels. Data are detailed in Figure 6 . IL-6 levels did not change following SO. They were significantly (50-fold increase during SO) elevated 6 and 16 hours after CLP. Increased serum levels were also noted at 6 and 16 hours following 2CLP. However, these elevations were substantially more pronounced than those observed following CLP. Indeed, in agreement with the findings of others, IL-6 levels increased nearly 1400-fold (2) and remained somewhat elevated throughout the time course studied. These data indicate that the absence of extracellular IL-6 cannot explain the decreased signal transduction following 2CLP.
DISCUSSION
The data presented here demonstrate impaired IL-6 signal transduction in a wellvalidated, well-accepted, and reproducible model of intraperitoneal sepsis in mice. Specifically, we found a late decrease in STAT-3 DNA binding activity and of p-STAT-3 in the nucleus following 2CLP, a model of fulminant sepsis. This occurred in a setting in which serum IL-6 levels were markedly elevated, a finding that indicates attenuation of the intracellular IL-6 signal transduction pathway. Further, the study revealed nuclear STAT-3 levels that were qualitatively reciprocal to those in the cytoplasm. Our data suggest that altered gp130 phosphorylation is of primary importance in the observed alteration in IL-6 activity.
The late loss of IL-6 signaling in a setting of elevated serum levels is a finding that we have observed previously following 2CLP in rats (4) . Therefore, we conducted a systematic, step-by-step investigation of the key elements involved in the intracellular IL-6 pathway-STAT-3, JAK-1, and gp130. Abundance of these elements was not altered. This indicates that the observed transcriptional defect in proteins of hepatic origin that we have noted previously is not an underlying cause (8, 11, 12) . Altered gp130 phosphorylation represents the most upstream abnormality we observed, and therefore we presume it is of primary importance. Certainly, impaired gp130 phosphorylation is consistent with our finding of attenuated nuclear p-STAT-3 levels and STAT-3 binding activity. The latter, in turn, is known to parallel mortality in sepsis (4). Sepsis-associated impairment of phosphorylation has been noted in other pathways (13) (14) (15) , including our own unpublished work on hepatic NF-B. Of potential importance, Ling et al (15) found that endotoxemia inhibited JAK-1 phosphorylation. They also found impaired phosphorylation of gp130 but attributed this to loss of JAK-1 kinase activity. However, lipopolysaccharide induces toxic changes in the liver that differ significantly from those induced by sepsis. Therefore, our observation of an alteration in gp130 phosphorylation represents a unique, previously unreported change during sepsis or any other disease. This indicates that the approaches designed to maintain or transfer phosphate groups may have therapeutic potential.
There are several possible explanations for altered gp130 phosphorylation. Indeed, the observed defect may represent an imbalance in the normal regulatory or counter-regulatory activity of kinases and phosphatases. One simple explanation is an energy defect that limits phosphate transfer. Levy et al (16) and others (17, 18) have demonstrated impaired mitochondrial function in sepsis. This would result in a reduced energy supply for phosphorylation. Similarly, Ince and Sinaasappel (19) have invoked a defect in the microcirculation that would limit adenosine triphosphate generation via attenuated oxygen delivery. Sepsis-induced attenuation of gp130 phosphorylation may also be because of failed JAK-1 kinase activity. Activity assays of this process involve complex experimental techniques that require significant refinement in current approaches to isolation of liver tissues. In addition, we did not directly examine gp130 kinase activity. This requires isolation of the enzymatic complex, a process that so far has not been accomplished in vivo. Alternatively, phosphate groups might be removed at an accelerated rate. Liver is rich in phosphatases. For example, the (SH2)-containing tyrosine phosphatase SHP-2 interacts specifically with JAK-1 and gp130 tyrosine residues (20, 21) . In addition, suppressors of cytokine signaling-3 bind to gp130 (as well as JAK-1) with high affinity (21) and specifically affect tyrosine phosphorylation (22, 23) . This interaction occurs without inhibition of JAK-1 activity (23, 24) . Another SOCS family member, SOCS-1, reduces tyrosine phosphorylation of both gp130 and STAT-3 (25) .
Importantly, gp130 is a ligand for a number of other extracellular mediators. These include, among others, leukemia inhibitory factor, IL-11, oncostatin, and neuropoetin. However, there is little in the literature regarding the importance of these in sepsis-induced hepatic dysfunction. Conversely, IL-6 is universally regarded as a key mediator of septic effects. Nonetheless, our data might reflect an impaired response to one of these other cytokines along with IL-6. Figure 5 . Association of janus kinase (JAK)-1 and glycoprotein (gp)130 following sham operation, cecal ligation and single puncture (CLP), and cecal ligation and double puncture (2CLP). Autoradiograms of representative immunoblots following sham operation, CLP, and 2CLP. Cytosolic protein extract immunoprecipitated with an antibody to either gp130 or JAK-1 and subjected to 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis after transfer blot probed with antibody to whichever protein had not been immunoprecipitated. The above autoradiogram reflects immunoprecipitation with an antibody to JAK-1 and detection with an antibody to gp130. Results were the same when we immunoprecipitated with an antibody to gp130 and probed with an antibody to JAK-1. Data from 24, 48, and 72 hours postprocedure because these were the time points at which IL-6 signaling was impaired. 
